BioNTech SE (BNTX)

[Man6677]

BioNTech SE (BNTX) Gets a Hold Rating from J.P. Morgan

Source: TipRanks
J.P. Morgan analyst Cory Kasimov maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $183.00. The company's shares closed last Monday at $140.32, close to its 52-week low of $121.32. According to TipRanks.com, Kasimov is a 5-star analyst with an average return of 18.2% and a 54.4% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, BioMarin Pharmaceutical, and Allogene Therapeutics. Currently, the analyst consensus on BioNTech SE is a Moderate Buy with an average price target of $251.89, an 80.5% upside from current levels.
https://www.tipranks.com/news/blurbs/biontech-se-bntx-gets-a-hold-rating-from-j-p-morgan?utm_source=advfn.com&utm_medium=referral

BNTX $$$$